Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Heike I Grabsch"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł :
Hypothesis‐free deep survival learning applied to the tumour microenvironment in gastric cancer
Autorzy :
Armin Meier
Katharina Nekolla
Lindsay C Hewitt
Sophie Earle
Takaki Yoshikawa
Takashi Oshima
Yohei Miyagi
Ralf Huss
Günter Schmidt
Heike I Grabsch
Pokaż więcej
Temat :
gastric cancer
deep learning
survival analysis
computational pathology
tumour infiltrating immune cells
Ki67
Pathology
RB1-214
Źródło :
The Journal of Pathology: Clinical Research, Vol 6, Iss 4, Pp 273-282 (2020)
Opis pliku :
electronic resource
Relacje :
https://doaj.org/toc/2056-4538
Dostęp URL :
https://doaj.org/article/214b0075da184485a1149f62c1e0253f
Czasopismo naukowe
Tytuł :
Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
Autorzy :
David P.J. vanDijk
Astrid M.H. Horstman
Joey S.J. Smeets
Marcel denDulk
Heike I. Grabsch
Cornelis H.C. Dejong
Sander S. Rensen
Steven W.M. Olde Damink
Luc J.C. vanLoon
Pokaż więcej
Temat :
Protein metabolism
Pancreatic cancer
Pancreas
Liver
Diseases of the musculoskeletal system
RC925-935
Human anatomy
QM1-695
Źródło :
Journal of Cachexia, Sarcopenia and Muscle, Vol 10, Iss 3, Pp 549-556 (2019)
Opis pliku :
electronic resource
Relacje :
https://doaj.org/toc/2190-5991; https://doaj.org/toc/2190-6009
Dostęp URL :
https://doaj.org/article/c878c9acc08c4f1fa5d6b39793b9c945
Czasopismo naukowe
Tytuł :
EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Autorzy :
Anna Dorothea Wagner
Heike I. Grabsch
Murielle Mauer
Sandrine Marreaud
Carmela Caballero
Peter Thuss-Patience
Lothar Mueller
Annelie Elme
Markus Hermann Moehler
Uwe Martens
Yoon-Koo Kang
Sun Young Rha
Annemieke Cats
Masanori Tokunaga
Florian Lordick
Pokaż więcej
Temat :
Gastric cancer
Gastro-esophageal junction cancer
Perioperative chemotherapy
Trastuzumab
Pertuzumab
HER2
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło :
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Opis pliku :
electronic resource
Relacje :
http://link.springer.com/article/10.1186/s12885-019-5675-4; https://doaj.org/toc/1471-2407
Dostęp URL :
https://doaj.org/article/868882dd5c1b417b8578bb744368f13f
Czasopismo naukowe
Tytuł :
Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future
Autorzy :
Rachel S. van der Post
Irene GulloAff4 Aff5 Aff6
Carla OliveiraAff4 Aff5
Laura H. Tang
Heike I. Grabsch
Maria O’Donovan
Rebecca C. Fitzgerald
Han van Krieken
Fátima CarneiroAff4 Aff5 Aff6
Pokaż więcej
Źródło :
Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract. :371-391
Książka elektroniczna
Tytuł :
RandomSpot: A web-based tool for systematic random sampling of virtual slides
Autorzy :
Alexander I Wright
Heike I Grabsch
Darren E Treanor
Pokaż więcej
Temat :
Random sampling, randomspot, systematic, web system
Computer applications to medicine. Medical informatics
R858-859.7
Pathology
RB1-214
Źródło :
Journal of Pathology Informatics, Vol 6, Iss 1, Pp 8-8 (2015)
Opis pliku :
electronic resource
Relacje :
http://www.jpathinformatics.org/article.asp?issn=2153-3539;year=2015;volume=6;issue=1;spage=8;epage=8;aulast=Wright; https://doaj.org/toc/2153-3539
Dostęp URL :
https://doaj.org/article/bd3d0e764dc34b48aa00cc7d686ee159
Czasopismo naukowe
Tytuł :
Erratum to: Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future
Autorzy :
Rachel S. van der Post
Irene GulloAff4 Aff5 Aff6
Carla OliveiraAff4 Aff5
Laura H. Tang
Heike I. Grabsch
Maria O’Donovan
Rebecca C. Fitzgerald
Han van Krieken
Fátima CarneiroAff4 Aff5 Aff6
Pokaż więcej
Źródło :
Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract. :E1-E1
Materiał oryginalny :
The updated original online version for this chapter can be found at http://dx.doi.org/10.1007/978-3-319-41388-4_18
Książka elektroniczna
Tytuł :
Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability.
Autorzy :
Heike I Grabsch
Jon M Askham
Ewan E Morrison
Natalja Pomjanski
Kristina Lickvers
Wendy J Parsons
Alfred Boecking
Helmut E Gabbert
Wolfram Mueller
Pokaż więcej
Temat :
STOMACH cancer
CHROMOSOMES
BENZIMIDAZOLES
GENE expression
DNA
CARCINOGENESIS
Źródło :
Journal of Pathology; Feb2004, Vol. 202 Issue 2, p208-214, 7p
Czasopismo naukowe
Tytuł :
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial.
Autorzy :
Smyth EC; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Fassan M; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Cunningham D; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Allum WH; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Okines AF; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Lampis A; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Hahne JC; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Rugge M; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Peckitt C; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Nankivell M; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Langley R; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Ghidini M; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Braconi C; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Wotherspoon A; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Grabsch HI; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands.
Valeri N; Elizabeth C. Smyth, David Cunningham, William H. Allum, Alicia F.C. Okines, Clare Peckitt, Chiara Braconi, Andrew Wotherspoon, and Nicola Valeri, Royal Marsden Hospital; Andrea Lampis, Jens C. Hahne, Michele Ghidini, Chiara Braconi, and Nicola Valeri, The Institute of Cancer Research, London and Sutton; Matthew Nankivell and Ruth Langley, Medical Research Council Clinical Trials Unit at UCL, London; Heike I. Grabsch, University of Leeds, Leeds, United Kingdom; Matteo Fassan and Massimo Rugge, University of Padua, Padua, Italy; and Heike I. Grabsch, Maastricht University Medical Center, Maastricht, the Netherlands. .
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Aug 10; Vol. 34 (23), pp. 2721-7. Date of Electronic Publication: 2016 Jun 13.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymph Node Excision*
Adenocarcinoma/*drug therapy
Adenocarcinoma/*secondary
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Esophageal Neoplasms/*drug therapy
Esophageal Neoplasms/*pathology
Lymph Nodes/*pathology
Stomach Neoplasms/*drug therapy
Stomach Neoplasms/*pathology
Adenocarcinoma/genetics ; Adenocarcinoma/surgery ; Aged ; Chemotherapy, Adjuvant ; Cisplatin/administration & dosage ; Class I Phosphatidylinositol 3-Kinases ; Epirubicin/administration & dosage ; Esophageal Neoplasms/genetics ; Esophageal Neoplasms/surgery ; Female ; Fluorouracil/administration & dosage ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoadjuvant Therapy ; PTEN Phosphohydrolase/genetics ; Phosphatidylinositol 3-Kinases/genetics ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Receptor, ErbB-2/genetics ; Stomach Neoplasms/genetics ; Stomach Neoplasms/surgery ; Survival Rate ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies